Laser in der Augenheilkunde: Evidenzlage

Das hier ist meine ganzheitliche Kompilation von evidenzbasierter Anwendung der Laser in der Augenheilkunde: Laser-Evidenzbasiert.
Hier sind Laser-Trabekuloplastik, Kapsulotomie, Iridotomie, Iridoplastik, fokale Laserkoagulation der Makula bei diabetischem Makulaödem und bei Makulaödem bei VAV und panretinale Laserkoagulation bei proliferativer diabetischer Retinopathie und ZVV gedeckt.
Referenzen (meistens RCTs und nationale und internationale Leitlinien, sowie Lehrbücher, wo da keine RCTs verfügbar waren):

Allgemeinlehrbücher
1 Checkliste Augenheilkunde 2018
2 Augustin, Augenheilkunde, 3. Aufl. 2007
3 Wills Eye Manual 7th ed. (2017)

Glaukom
4 Color Atlas of Gonioscopy – Allward Allen 2001 (AAO Foundation)
5 European Glaucoma Guidelines 5. ed. (2020) https://www.eugs.org/eng/egs_guidelines_download.asp
31 RCT: Prevention of the immediate intraocular pressure rise following argon laser trabeculoplasty. (1989) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1041828/
32 Cochrane Review: Peripheral iridotomy for pigmentary glaucoma (2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032906/
33 Cochrane Review: Iridotomy to slow progression of visual field loss in angle‐closure glaucoma (2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026549/
34 Laser Peripheral Iridotomy in Primary Angle Closure. Ophthalmology (2018). A Report by the American Academy of Ophthalmology https://pubmed.ncbi.nlm.nih.gov/29482864/
35 AAO Primary Angle Closure Prefered Practice Patterns (2020) https://www.aao.org/preferred-practice-pattern/primary-angle-closure-disease-ppp
36 RCT: YAG-IT superior VS temporal/nasal. Dysphotopsia after temporal versus superior laser peripheral iridotomy: a prospective randomized paired eye trial (2014) https://pubmed.ncbi.nlm.nih.gov/24531024/
37 RCT: YAG-IT superior VS temporal/nasal. Comparison of New Visual Disturbances after Superior versus Nasal/Temporal Laser Peripheral Iridotomy: A Prospective Randomized Trial (2018) https://pubmed.ncbi.nlm.nih.gov/29096997/, https://pubmed.ncbi.nlm.nih.gov/30315902/
38 RCT: YAG-IT Nutzen bei PACS. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. Lancet (2019) https://pubmed.ncbi.nlm.nih.gov/30878226/

Periphere reinale Degenerationen
6 RUS Leitlinien: Periphere retinale Degenerationen (Периферические дегенерации сетчатки), 2019 http://avo-portal.ru/doc/fkr/development/item/326-perifericheskie-degeneratsii-setchatki
7 V.A. Shaimova, Peripheral retinal degenerations. 2017 (Rus, Eng.)
8 L’Esperance FA jr. Ophthalmic lasers, 3rded. Vol. 1. StLouis: CV Mosby Co, 1989;78–112
9 Ryan’s Retina (3 Volumes), 6th Edition (2017)
10 Duane‘s Ophthalmology, 2012 ed.
11 Ophthalmology 5th Ed. Myron Yanoff, Jay Duker (2018)
12 Leitlinie der DOG und des BVA Nr. 22a, Vorstufen einer rhegmatogenen Netzhautablösung bei Erwachsenen (2011) https://www.dog.org/wp-content/uploads/2009/09/Leitlinie-Nr.-22-a-Vorstufen-einer-rhegmatogener-Netzhautabl%C3%B6sung-bei-Erwachsenen-17.11.2011.pdf
30 AAO PPP Posterior Vitreous Detachment, Retinal Breaks and Lattice Degeneration (2019) https://www.aao.org/preferred-practice-pattern/posterior-vitreous-detachment-retinal-breaks-latti

Diabetische Retinopathie
13 AAO PPP Diabetic Retinopathy 2019
14 ICO Guidelines for Diabetic Eye Care 2017 http://www.icoph.org/downloads/ICOGuidelinesforDiabeticEyeCare.pdf
15 EURETINA DME Guidelines 2017 https://www.karger.com/Article/FullText/458539
16 Nationale VersorgungsLeitlinie Prävention und Therapie von Netzhautkomplikationen bei Diabetes (Bundesärztekammer, Kassenärztliche Bundesvereinigung, 2015) https://www.leitlinien.de/mdb/downloads/nvl/diabetes-mellitus/dm-netzhautkomplikationen-2aufl-vers2-lang.pdf
17 Statement of the German Ophthalmological Society, the Retinological Society and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Situation August 2019 [Stellungnahme der DOG, der RGund des BVA zur Therapie desdiabetischen Makulaödems] (2019) https://pubmed.ncbi.nlm.nih.gov/31932952/ Ergänzende Stellungnahme zur Therapie der proliferativen diabetischen Retinopathie (DOG, RG, BVA, 2019) https://www.retinologie.org/fileadmin/Dateien/RG_Behandlungsempfehlungen/2019_Therapie_der_proliferativen_diabetischen_Retinopathie_-_ergaenzend.pdf
18 RCT DRS: PRP für PDR, Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group (1987) https://pubmed.ncbi.nlm.nih.gov/2447027/
19 RCT ETDRS DME: Photocoagulation for Diabetic Macular Edema, Early Treatment Diabetic Retinopathy Study Report Number 1 Early Treatment Diabetic Retinopathy Study Research Group (1985) https://jamanetwork.com/journals/jamaophthalmology/article-abstract/635820 Early Treatment Diabetic Retinopathy Study Research Group: Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Report Number 2. Ophthalmology 1987;94:761-774. USA https://www.sciencedirect.com/science/article/abs/pii/S0161642087335274
20 RCT ETDRS PRP: Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group (1991), https://pubmed.ncbi.nlm.nih.gov/2062512/ RCT ETDRS PRP, Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. (1987), https://pubmed.ncbi.nlm.nih.gov/3692707/
21 RCT DRCR.Net PRP Vs Ranibisumab for PDR (Protocol S), 2015-2018, PMID: 26565927 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567801/, PMC6233839 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233839/
22 RCT DRCR.Net Modified ETDRS vs Mild Macular Grid for DME: Comparison of Modified-ETDRS and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular Edema (2007), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536574/ RCT DRCR.Net TCA Vs Macular Grid. Network DRCR: A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-1459.e1410. https://pubmed.ncbi.nlm.nih.gov/18662829/
23 Syst.Review: Mohamed, Q., Gillies, M. C., & Wong, T. Y. (2007). Management of Diabetic Retinopathy. JAMA. https://pubmed.ncbi.nlm.nih.gov/17712074/
24 RCT: PRP für nicht proliferative DR: Lovestam-Adrian, M., Agardh, C.-D., Torffvit, O., & Agardh, E. (2003). Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation. Acta Ophthalmologica Scandinavica, https://pubmed.ncbi.nlm.nih.gov/12780397/

Netzhautvenenverschlüsse
25 RCT CVOS. A Randomized Clinical Trial of Early Panretinal Photocoagulation for Ischermic Central Vein Occlusion. (1995). Ophthalmology, 102(10), 1434–1444 https://pubmed.ncbi.nlm.nih.gov/9097789/
26 RCT BVOS. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98(3):271-282 https://pubmed.ncbi.nlm.nih.gov/6383055/ RCT BVOS. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a RCT. Arch Ophthalmol. 1986;104(1):34-41 https://pubmed.ncbi.nlm.nih.gov/2417579/
27 AAO PPP Retinal Vein Occlusions 2019
28 Stellungnahmedes Berufsverbandes der Augenärzte Deutschlands, der Deutschen Ophthalmologischen Gesellschaft und der Retinologischen Gesellschaft: Intravitreale Therapie des visusmindernden Makulaödems bei retinalem Venenverschluss, Therapeutische Strategien (2018) https://www.dog.org/wp-content/uploads/2013/03/Intravitreale-Therapie-des-visusmindernden-Makula%C3%B6dems-bei-retinalem-Venenverschluss-2018-04.pdf

Nachstar
29 Leitlinie Nr.19b Nd:YAG-Laser Kapsulotomie des Nachstars (2012) https://www.dog.org/wp-content/uploads/2009/09/Leitlinie-Nr.-19-b-Nd-YAG-Laser-Kapsulotomie-des-Nachstars.pdf

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert.